AnorMED conference call notification - AnorMED recommends shareholders reject dissident slate of director nominees
27 März 2006 - 4:24PM
PR Newswire (US)
VANCOUVER, March 27 /PRNewswire-FirstCall/ -- AnorMED Inc. (TSX:
AOM) announced that it will hold a conference call and web cast
today, Monday March 27, 2006 at 9:00 a.m. EST (6:00 a.m. PST) to
discuss its recommendation to support the current AnorMED
Management Team and Proposed Slate of Directors and reject The
Baker Group's proposed slate. The web cast can be accessed through
the company's web site at http://www.anormed.com/. To listen to the
teleconference please dial 1-800-558-5253 in Canada and the U.S. or
1-416-626-4100 Internationally at 9:00 am EST. The reservation
number required for access is No. 21288034. Participants will be in
listen only mode. This call will be available on replay until April
26, 2006. AnorMED is a chemistry- based biopharmaceutical company
focused on the discovery, development and commercialization of new
therapeutic products in the areas of hematology, HIV and oncology.
Information on AnorMED Inc. is available on the Company's website:
http://www.anormed.com/. For further information: Elisabeth
Whiting, M.Sc., Vice President, Corporate Development &
Communications, Tel: (604) 532-4667, e-mail: DATASOURCE: AnorMED
Inc. CONTACT: Elisabeth Whiting, M.Sc., Vice President, Corporate
Development & Communications, Tel: (604) 532-4667, e-mail:
Copyright